Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-26

Clinical Trial Update: Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 1/2 evaluation of prazosin for chronic postconcussive headache, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Headache, Combat Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-26